Latest Lead News

SiteMinder Limited reported robust FY25 results with a 27.2% constant currency organic ARR increase and a return to positive underlying EBITDA, driven by its innovative Smart Platform and expanding global footprint.

SiteMinder Limited reported a 17.7% revenue increase to $224.3 million in FY2025, alongside a reduced net loss and positive underlying EBITDA, driven by its innovative Smart Platform strategy and expanding customer base.

ParagonCare Limited reported a solid FY25 with $3.6 billion in revenue and $95.2 million underlying EBITDA, marking progress in its integration and growth strategy across Asia Pacific. The company is poised for further profitability improvements and expansion in FY26.

Paragon Care Limited reported solid FY25 results with revenue climbing to $3.61 billion and underlying EBITDA rising 3%, driven by successful integration and expansion into new healthcare segments.

Paragon Care Limited reported a robust 22% increase in revenue to $3.61 billion for FY25, driven by organic growth and key acquisitions including CH2 Holdings and Oborne Health Supplies. The company also refinanced its debt facilities and expanded into the dental market post-year-end.

MyEco Group Ltd reported an 8.6% revenue increase to $15.7 million in FY25, driven by strong growth in its MyEco® branded products and improved margins. The company cut its net loss by nearly half, supported by operational restructuring and expanding market presence.

Australian Finance Group Ltd (AFG) reported a 21% rise in statutory net profit after tax to $35 million for FY25, driven by record broker numbers and loan book growth. The company declared a fully franked final dividend of 5.3 cents per share, underscoring strong shareholder returns.

Meridian Energy posted a significant net loss for FY25 due to severe droughts and gas shortages but pushed ahead with renewable investments and maintained shareholder dividends.

EBOS Group Limited reported solid FY25 results with 12% revenue growth and strategic acquisitions, setting sights on continued expansion and operational efficiency in FY26.

Race Oncology Limited reported a significantly reduced loss for FY2025, driven by key clinical trial progress and strategic leadership changes. The company advances its RC220 program with promising Phase 1 dosing milestones and strengthens its governance to support future growth.

Atturra Limited has become the first Australian Microsoft Solutions Partner to earn the Private Cloud Solution Partner designation, underscoring its leadership in sovereign and hybrid cloud services for critical sectors.

Star Combo Pharma has reported a remarkable jump in profit for FY2025, driven by strong revenue growth and a settled insurance claim, while declaring its second dividend and planning production expansion.